New Brain Cancer Drug Passes Phase One of Trial
An experimental drug being trialled for advanced tumours has passed phase one of its Australian trial, with the second phase set to test the drug’s effectiveness against the most aggressive brain cancer—glioblastoma.
Starting in June 2021, the first phase involved patients with glioblastoma, as well as cervical, pancreatic, colon, gastrointestinal, and uterine cancers, with the aim of testing whether the drug Auceliciclib was safe at different dosages.
Prof. Shudong Wang from the University of South Australia (UniSA) told The Epoch Times via email on Monday that “the drug showed an excellent safety profile even in those who are in extremely poor health due to their previous multiple lines of treatment with chemotherapies, and who are at the latest stage of disease,” adding that there were also some early signs of efficacy….